Page last updated: 2024-11-10

12-hydroxy-5,8,14-eicosatrienoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

12-hydroxy-5,8,14-eicosatrienoic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5283149
CHEMBL ID329415
CHEBI ID184584
SCHEMBL ID1476546
MeSH IDM0185016

Synonyms (14)

Synonym
CHEMBL329415
12(r)dh-hete
5,8,14-eicosatrienoic acid, 12-hydroxy-, (r-(z,z,z))-
12-hydroxy-5,8,14-eicosatrienoic acid
12r-hydroxy-5z,8z,12z-eicosatrienoic acid
LMFA03050012 ,
12r-hetre
(5z,8z,12r,14z)-12-hydroxyicosa-5,8,14-trienoic acid
117346-20-0
CHEBI:184584
SCHEMBL1476546
12-hydroxy-5,8,14-eicosatrienoic acid, (z,z,z)-isomer
12r-hydroxy-5z,8z,12z-eicosatrienoate
12-hydroxy-5,8,14-eicosatrienoic acid, (s-(z,z,z))-isomer
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
hydroxy fatty acidAny fatty acid carrying one or more hydroxy substituents.
polyunsaturated fatty acidAny fatty acid containing more than one double bond. Acids in this group are reported to have cardioprotective effects; and levels are lowered in chronic fatigue syndrome.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (60.00)18.2507
2000's4 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.84 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.24 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]